All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Security
Security
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

ChEA-KG: A network-based transcription factor enrichment analysis tool with time-series workflow capabilities

By

Byrd, Anna I, Evangelista, John Erol, Van Dusen, Andrew, Clarke, Daniel J B, Berrada, Maha, Jenkins, Sherry L, Ma’ayan, Avi

2h ago· 40 min readenInsight

Summary

The article presents ChEA-KG, a network-based transcription factor (TF) enrichment analysis tool, along with an accompanying time-series workflow called ChEA-KG-TS. The tool generates enriched TF regulatory subnetworks for input gene sets, based on a gene regulatory network (GRN) connecting 1,559 human TFs via 131,181 signed and directed edges inferred from diverse published ChIP-seq data. This enables researchers to identify context-specific TF subnetworks and understand how TF modules evolve over time in normal physiology and disease.

Source

bskyChEA-KG: A network-based transcription factor enrichment analysis tool with time-series workflow capabilitiesdoi.org

Key quotes

· 3 pulled
Transcription factor (TF) modules interact to regulate key biological processes and cell-state transitions in normal physiology and disease.
To identify context-specific TF subnetworks, we developed ChEA-KG, which generates enriched TF regulatory subnetworks for input gene sets.
ChEA-KG is based on a GRN connecting 1559 human TFs via 131181 signed and directed edges inferred from diverse published ChIP-seq data.
Snippet from the RSS feed
Abstract. Transcription factor (TF) modules interact to regulate key biological processes and cell-state transitions in normal physiology and disease. Unde

You might also wanna read

Comments

Sign in to join the conversation.

No comments yet. Be the first.